GKOS
Glaukos Corporation · Healthcare · Medical - Devices
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +4.6% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 125 | +9 | 42.85M | $5.95B | +15 | −5 |
| Q1 2026 | 118 | -1 | 46.55M | $5.02B | +6 | −8 |
| Q4 2025 | 118 | 0 | 48.22M | $5.44B | +2 | −1 |
| Q3 2025 | 22 | +5 | 29.69M | $2.42B | +5 | −1 |
| Q2 2025 | 15 | -2 | 32.65M | $3.37B | +1 | −3 |
| Q1 2025 | 14 | -2 | 8.81M | $867.57M | +1 | −3 |
| Q4 2024 | 16 | -1 | 9.74M | $1.46B | — | −1 |
| Q3 2024 | 16 | 0 | 7.06M | $919.99M | +1 | −1 |
| Q2 2024 | 16 | — | 6.75M | $798.69M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.18M | +294.5% | $284.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.18M | +294.5% | $284.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.18M | +294.5% | $284.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.18M | +294.5% | $284.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.18M | +294.5% | $284.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 1.25M | +2.0% | $162.22M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passiv) | 1.17M | +6.0% | $152.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passiv) | 1.17M | +6.0% | $152.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Capital World Investors ✦ | 550.32K | 0.0% | $71.70M | 0.0% | Held | 2 | SEC ↗ |
| 10 | Norges Bank ✦ (passiv) | 532.13K | -1.1% | $69.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 383.40K | -32.7% | $49.95M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 359.45K | -32.0% | $46.83M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 242.23K | -81.0% | $31.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Millennium Management ✦ | 242.23K | -81.0% | $31.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 173.40K | -13.3% | $22.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 128.80K | Neu | $16.78M | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 128.80K | Neu | $16.78M | 0.0% | New | 1 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 37.99K | -68.8% | $4.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 30.95K | -5.2% | $4.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Bridgewater Associates ✦ | 8.37K | -9.3% | $1.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 6.53K | +57.7% | $850,598 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 6.53K | +57.7% | $850,598 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 5.27K | -4.3% | $686,576 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 1.56K | -94.3% | $203,237 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 1.56K | -94.3% | $203,237 | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Marshall Wace | $16.78M | 0.0% |
| Marshall Wace | $16.78M | 0.0% |
Ausgestiegen
| Gotham Asset Management | $284,868 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 333 Inhaber, 57.55M Anteile, $6.09B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Director · 2.50K Ant. · $475,000
Officer · 27.96K Ant. · $5.00M
Officer · 32.04K Ant. · $5.78M
Officer · 20.00K Ant. · $3.60M
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik